Global bionetworks and challenges in regulating autologous adult stem cells

Tamra Lysaght; Ian Kerridge; Douglas Sipp; Gerard Porter; Benjamin J. Capps

doi:10.1016/j.amjmed.2013.06.031

Global bionetworks and challenges in regulating autologous adult stem cells

Tamra Lysaght, Ian Kerridge, Douglas Sipp, Gerard Porter, Benjamin J. Capps

Résultat de recherche: Comment/debate › examen par les pairs

Langue d'origine	English
Pages (de-à)	941-943
Nombre de pages	3
Journal	American Journal of Medicine
Volume	126
Numéro de publication	11
DOI	https://doi.org/10.1016/j.amjmed.2013.06.031
Statut de publication	Published - nov. 1 2013
Publié à l'externe	Oui

Note bibliographique

Funding Information:
The research for this article was conducted as part of the “Asian Biopoleis: Biotechnology and Biomedicine as Emergent Forms of Life and Practice” project, funded by the Ministry of Education, Singapore , and the Humanities and Social Sciences Division of the Office of the Deputy President (Research and Technology) at the National University of Singapore.

Funding Information:
The concept of bionetworks has been described in a study 3 funded by the Ethics & Social Science Research Council in the United Kingdom. This study traces the relationships among physicians, science entrepreneurs, researchers, patients, and healthcare providers who are offering adult stem cells outside clinical trials as experimental therapies across Asia. According to the authors, bionetworks operate mostly, although not exclusively, within the private healthcare sector and work to exploit differences and similarities in the provision of healthcare, standards of evidence, and regulatory infrastructure across geographic contexts. 4 They also may work to shape healthcare policies and regulations across international borders.

ASJC Scopus Subject Areas

General Medicine

Accès au document

10.1016/j.amjmed.2013.06.031

Autres fichiers et liens

Citer

@article{8999dd20ac4f49c1b30c42b59de96bc3,

title = "Global bionetworks and challenges in regulating autologous adult stem cells",

author = "Tamra Lysaght and Ian Kerridge and Douglas Sipp and Gerard Porter and Capps, {Benjamin J.}",

note = "Funding Information: The research for this article was conducted as part of the “Asian Biopoleis: Biotechnology and Biomedicine as Emergent Forms of Life and Practice” project, funded by the Ministry of Education, Singapore , and the Humanities and Social Sciences Division of the Office of the Deputy President (Research and Technology) at the National University of Singapore. Funding Information: The concept of bionetworks has been described in a study 3 funded by the Ethics & Social Science Research Council in the United Kingdom. This study traces the relationships among physicians, science entrepreneurs, researchers, patients, and healthcare providers who are offering adult stem cells outside clinical trials as experimental therapies across Asia. According to the authors, bionetworks operate mostly, although not exclusively, within the private healthcare sector and work to exploit differences and similarities in the provision of healthcare, standards of evidence, and regulatory infrastructure across geographic contexts. 4 They also may work to shape healthcare policies and regulations across international borders. ",

year = "2013",

month = nov,

day = "1",

doi = "10.1016/j.amjmed.2013.06.031",

language = "English",

volume = "126",

pages = "941--943",

journal = "American Journal of Medicine",

issn = "0002-9343",

publisher = "Elsevier Inc.",

number = "11",

}

TY - JOUR

T1 - Global bionetworks and challenges in regulating autologous adult stem cells

AU - Lysaght, Tamra

AU - Kerridge, Ian

AU - Sipp, Douglas

AU - Porter, Gerard

AU - Capps, Benjamin J.

N1 - Funding Information: The research for this article was conducted as part of the “Asian Biopoleis: Biotechnology and Biomedicine as Emergent Forms of Life and Practice” project, funded by the Ministry of Education, Singapore , and the Humanities and Social Sciences Division of the Office of the Deputy President (Research and Technology) at the National University of Singapore. Funding Information: The concept of bionetworks has been described in a study 3 funded by the Ethics & Social Science Research Council in the United Kingdom. This study traces the relationships among physicians, science entrepreneurs, researchers, patients, and healthcare providers who are offering adult stem cells outside clinical trials as experimental therapies across Asia. According to the authors, bionetworks operate mostly, although not exclusively, within the private healthcare sector and work to exploit differences and similarities in the provision of healthcare, standards of evidence, and regulatory infrastructure across geographic contexts. 4 They also may work to shape healthcare policies and regulations across international borders.

PY - 2013/11/1

Y1 - 2013/11/1

UR - http://www.scopus.com/inward/record.url?scp=84886394227&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886394227&partnerID=8YFLogxK

U2 - 10.1016/j.amjmed.2013.06.031

DO - 10.1016/j.amjmed.2013.06.031

M3 - Comment/debate

C2 - 24157285

AN - SCOPUS:84886394227

SN - 0002-9343

VL - 126

SP - 941

EP - 943

JO - American Journal of Medicine

JF - American Journal of Medicine

IS - 11

ER -